RESÚMENES JUNIO 2009

.

Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Environmental Adversity and Increasing Genetic Risk for Externalizing Disorders

Brian M. Hicks, Susan C. South, Ana C. DiRago, William G. Iacono, Matt McGue

Arch Gen Psychiatry. 2009;66(6):640-648

 

3 - Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)

Elisabetta Poluzzi, Emanuel Raschi, Ugo Moretti, Fabrizio De Ponti

Pharmacoepidemiology and Drug Safety. Volume 18 Issue 6, Pages 512 - 518

 

5< - Vitamin E Paradox in Alzheimer's Disease: It Does Not Prevent Loss of Cognition and May Even Be Detrimental

Ana Lloret, Mari-Carmen Badía, Nancy J. Mora, Federico V. Pallardó, Maria-Dolores Alonso, Jose Viña

Journal of Alzheimer's Disease. Volume 17, Number 1 / 2009:143-149

 

3 - Does Vitamin D Reduce the Risk of Dementia?

William B. Grant

Journal of Alzheimer's Disease. Volume 17, Number 1 / 2009:151-159

 

3! - Delusion Symptoms and Response to Antipsychotic Treatment are Associated with the 5-HT2A Receptor Polymorphism (102T/C) in Alzheimer's Disease: A 3-Year Follow-up Longitudinal Study

Francesco Angelucci, Sergio Bernardini, Paolo Gravina, Lorenza Bellincampi, Alberto Trequattrini, Fulvia Di Iulio, Diego Vanni, Giorgio Federici, Carlo Caltagirone, Paola Bossù, Gianfranco Spalletta

Journal of Alzheimer's Disease. Volume 17, Number 1 / 2009: 203-211

 

GRATIS 5< - A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Paul Shotbolt, Michael Samuel, Chris Fox, Anthony S David

Neuropsychiatric Disease and Treatment. Published Date May 2009

 

3 - The Hypothalamic-Pituitary-Adrenal Axis in Borderline Personality Disorder: A Review

Daniel J. Zimmerman; Lois Wonsun Choi-Kain

Harvard Review of Psychiatry, Volume 17, Issue 3 June 2009, pages 167 - 183

 

3 - Treatment of narcolepsy

Giuseppe Didato and Lino Nobili

Expert Review of Neurotherapeutics. June 2009, Vol. 9, No. 6, Pages 897-910

 

3! - Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption

LM Paterson, SJ Wilson, DJ Nutt, PH Hutson, M Ivarsson

Journal of Psychopharmacology, Vol. 23, No. 5, 475-486 (2009)

3! - Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers

LM Paterson, DJ Nutt, M Ivarsson, PH Hutson, SJ Wilson

Journal of Psychopharmacology, Vol. 23, No. 5, 487-494 (2009)

3 - Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study

Movement Disorders - Short Communication

Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study

Giuseppe Meco, Paola Stirpe, Fabrizio Edito, Carlo Purcaro, Marcella Valente, Silvia Bernardi and Nicola Vanacore

Journal of Neural Transmission. Volume 116, Number 7 / julio de 2009: 881-884

 

3 - Pharmacotherapy for women's sexual dysfunction

Rosemary Basson

Expert Opinion on Pharmacotherapy. July 2009, Vol. 10, No. 10, Pages 1631-1648

 

3 - Low-dose doxepin for the treatment of insomnia: emerging data

Harold W Goforth

Expert Opinion on Pharmacotherapy. July 2009, Vol. 10, No. 10, Pages 1649-1655

 

GRATIS 3 - Anticonvulsants in the treatment of aggression in the demented elderly: an update

Benedikt Amann, Johannes Pantel, Heinz Grunze, Eduard Vieta, Francesc Colom, Ana Gonzalez-Pinto, Dieter Naber and Harald Hampel

Clinical Practice and Epidemiology in Mental Health 2009, 5:14

 

3 - Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Dag Aarsland, Clive Ballard, Zuzana Walker, Fredrik Bostrom, Guido Alves, Katja Kossakowski, Iracema Leroi, Francisco Pozo-Rodriguez, Lennart Minthon and Elisabet Londos

The Lancet Neurology. Volume 8, Issue 7, July 2009, Pages 613-618

 

3 - Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

Schlatter, Chantal; Egger, Sabin S.; Tchambaz, Lydia; Krahenbuhl, Stephan

Drug Safety. 32(7):561-578, July 1, 2009

3 - Pharmacological Management of Delirium in Hospitalized Adults – A Systematic Evidence Review

Original Article

Pharmacological Management of Delirium in Hospitalized Adults – A Systematic Evidence Review

Noll Campbell, Malaz A. Boustani, Amir Ayub, George C. Fox, Stephanie L. Munger, Carol Ott, Oscar Guzman, Mark FarberAdetayo Ademuyiwa and Ranjeet Singh

Journal of General Internal Medicine. Volume 24, Number 7 / julio de 2009: 848-853

 

4 - Donepezil delays progression to AD in MCI subjects with depressive symptoms

P. H. Lu, S. D. Edland, E. Teng, K. Tingus, R. C. Petersen, J. L. Cummings, On behalf of The Alzheimer's Disease Cooperative Study Group

NEUROLOGY 2009;72:2115-2121

3! - The risks and costs of multiple-generic substitution of topiramate

M. S. Duh, P. E. Paradis, D. Latrémouille-Viau, P. E. Greenberg, S. P. Lee, M. B. Durkin, G. J. Wan, M.F.T. Rupnow, and J. LeLorier

NEUROLOGY 2009;72:2122-2129

3 - Duloxetine: In Patients with Fibromyalgia

Curran, Monique P

Drugs. 69(9):1217-1227, June 18, 2009

3 - Comorbid Depression in Dementia on Psychogeriatric Nursing Home Wards: Which Symptoms are Prominent?

Verkaik, Renate; Francke, Anneke L; van Meijel, Berno; Ribbe, Miel W; Bensing, Jozien M

American Journal of Geriatric Psychiatry: July 2009 - Volume 17 - Issue 7 - pp 565-573

 

3 - Clinically Significant Depressive Symptoms and Associated Factors in Community Elderly Subjects From Sao Paulo, Brazil

Barcelos-Ferreira, Ricardo; Pinto, Jony Arrais Jr; Nakano, Eduardo Yoshio; Steffens, David C; Litvoc, Júlio; Bottino, Cássio M. C

American Journal of Geriatric Psychiatry: July 2009 - Volume 17 - Issue 7 - pp 582-590

 

3! - The Association Between Dementia and Long-Term Use of Benzodiazepine in the Elderly: Nested Case-Control Study Using Claims Data

Wu, Chi-Shin; Wang, Sheng-Chang; Chang, I-Shou; Lin, Keh-Ming

American Journal of Geriatric Psychiatry: July 2009 - Volume 17 - Issue 7 - pp 614-620

 

3! - Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication

B G Druss, I Hwang, M Petukhova, N A Sampson, P S Wang and R C Kessler

Molecular Psychiatry (2009) 14, 728–737

 

3! - Amyloid Reduction by Amyloid-β Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease

Donna M. Wilcock, Nastaran Gharkholonarehe, William E. Van Nostrand, Judianne Davis, Michael P. Vitek, and Carol A. Colton

The Journal of Neuroscience, June 24, 2009, 29(25):7957-7965

 

3 - Review: Donepezil in Severe Alzheimer's Disease

Bengt Winblad

American Journal of Alzheimer's Disease and Other Dementias, Vol. 24, No. 3, 185-192 (2009)

3 - Switching from Donepezil Tablets to Rivastigmine Transdermal Patch in Alzheimer's Disease

Carl H. Sadowsky, Alan Dengiz, Jason T. Olin, Barbara Koumaras, Xiangyi Meng, Stephen Brannan, US38 study group

American Journal of Alzheimer's Disease and Other Dementias, Vol. 24, No. 3, 267-275 (2009)

3 - Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease

Haroon Siddique, Linda S. Hynan, and Myron F. Weiner

J Clin Psychiatry 2009;70(6):915-918

 

4 - Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

Harald Hampel, Michael Ewers, Katharina Bürger, Peter Annas, Anette Mörtberg, Anna Bogstedt, Lutz Frölich, Johannes Schröder, Peter Schönknecht, Matthias W. Riepe, Inga Kraft, Thomas Gasser, Thomas Leyhe, Hans-Jürgen Möller, Alexander Kurz, and Hans Basun

J Clin Psychiatry 2009;70(6):922-931

 

3 - Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation

Mohammad Reza Safarinejad

BJU International. Published Online: 22 Jun 2009

 

4 - Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder

Arnold, Lesley M; Hudson, James I; Wang, Fujun; Wohlreich, Madelaine M; Prakash, Apurva; Kajdasz, Daniel K; Chappell, Amy S

The Clinical Journal of Pain: July/August 2009 - Volume 25 - Issue 6 - pp 461-468

 

GRATIS 3 - Adjustment Disorder: epidemiology, diagnosis and treatment

Mauro Giovanni Carta, Matteo Balestrieri, Andrea Murru and Maria Carolina Hardoy

Clinical Practice and Epidemiology in Mental Health 2009, 5:15

 

3 - Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

Brian P. Brennan, Kate V. Fogarty, Jacqueline L. Roberts, Karina A. Reynolds, Harrison G. Pope Jr., James I. Hudson

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 5, Pages 423 - 428

 

GRATIS 3 - Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer’s Disease

Mary J. Savage and Diane E. Gingrich

DRUG DEVELOPMENT RESEARCH 70 : 125–144 (2009)

 

GRATIS 3 (previo registro) - Current Concepts in Psychodermatology

Joseph A. Locala
Current Psychiatry Reports 2009, 11: (3) 211-218

 

GRATIS 3! (previo registro) - Psychopharmacologic Treatment of Patients With HIV/AIDS

Stephen J. Ferrando

Current Psychiatry Reports 2009, 11: (3) 235-242

 

3 - Depression in Frontotemporal Dementia

David M. Blass, and Peter V. Rabins

Psychosomatics 50:239-247, May-June

.

Regresar a RESÚMENES JUNIO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.